JAMES KOBAN: Open Payments
NPI 1174589857 · SOMERSET, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 29 payments from 8 companies in 2025. Trend: 2023 $740 · 2024 $339 · 2025 $1,148
Food & beverage: $1,040Education: $109
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $362 |
| Teva Pharmaceuticals USA, Inc. | 3 | $208 |
| Janssen Pharmaceuticals, Inc | 4 | $189 |
| Otsuka America Pharmaceutical, Inc. | 3 | $162 |
| Alkermes, Inc. | 3 | $101 |
| E.R. Squibb & Sons, L.L.C. | 3 | $71 |
| Neurocrine BioSciences, Inc. | 2 | $35 |
| Lundbeck LLC | 1 | $20 |
Products named: CAPLYTA, INVEGA SUSTENNA, ABILIFY MAINTENA, UZEDY, LYBALVI, COBENFY, INGREZZA, ARISTADA.
Industry payments across PA — which companies pay providers there.
